查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1655536

二十碳五烯酸的世界市场

Eicosapentaenoic Acid
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 94 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球二十碳五烯酸市场规模将达到 65 亿美元

2024 年全球二十碳五烯酸市场规模估计为 35 亿美元，预计 2030 年将达到 65 亿美元，2024 年至 2030 年的复合年增长率为 10.9%。营养保健食品和机能性食品应用是报告中分析的细分市场之一，预计复合年增长率为 11.7%，到分析期结束时将达到 49 亿美元。在分析期内，宠物和动物食品应用领域预计将以 7.6% 的复合年增长率成长。

美国市场规模估计为 8.95 亿美元，中国市场预估年复合成长率为 14.4%

预计 2024 年美国二十碳五烯酸市值将达 8.95 亿美元。中国是世界第二大经济体，预计到 2030 年市场规模将达到 15 亿美元，2024-2030 年分析期间的复合年增长率为 14.4%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 7.1% 和 8.8%。在欧洲，预计德国的复合年增长率约为 8.1%。

全球二十碳五烯酸 (EPA) 市场 - 主要趋势与驱动因素摘要

什么是二十碳五烯酸 (EPA)？

二十碳五烯酸 (EPA) 是Omega-3脂肪酸，主要存在于脂肪鱼和某些藻类中。 EPA 是多不饱和脂肪酸，对人体健康起着重要作用，特别是在支持心血管功能、减少发炎和促进大脑健康方面。 EPA 因其抗发炎特性而受到广泛认可，使其成为管理各种健康状况（包括心血管疾病、关节炎和精神障碍）的重要营养素。此外，EPA 也被认为有助于合成称为二十烷酸的生物活性化合物，这有助于调节人体的各种生理过程。

EPA 在营养中的重要性因其众多的健康益处而凸显。定期摄取 EPA 可降低三酸甘油酯水平、减少心律不整的风险并降低血压，从而改善心臟健康。此外，EPA 在心理健康中也发挥着重要作用，摄取足量的这种脂肪酸可能有助于缓解忧郁症和焦虑的症状。随着消费者健康意识的增强，对富含 EPA 的食品和补充剂的需求不断增加，从而推动了 EPA 市场的成长。

EPA 的主要用途是什么以及它如何满足营养需求？

EPA 的主要用途是膳食补充剂、机能性食品、药物和动物营养。在膳食补充剂领域，EPA 通常以鱼油胶囊、磷虾油和藻类油补充剂的形式出售。这些产品的目标客户是希望增加Omega-3摄取量的消费者，以获得各种健康益处，包括支持心血管健康和减少发炎。 EPA 补充剂的受欢迎程度正在迅速提高，尤其是在註重健康的人和有特定健康问题的人中，导致此类产品的市场不断增长。

在机能性食品领域，EPA 越来越多地被加入到各种食品中，包括乳製品、食品和饮料产品以及点心棒。製造商已经意识到具有附加营养价值的健康产品的潜在市场。透过在日常食品中强化 EPA，品牌可以满足消费者寻求在饮食中添加有益的Omega-3脂肪酸的便捷方式的需求。随着寻求改善整体健康状况的消费者对健康机能性食品的需求不断增长，这一趋势尤其重要。

EPA 在製药业也受到关注，其治疗应用正在受到考虑。目前正在进行调查，以评估 EPA 在治疗各种医疗状况（包括心血管、发炎和精神疾病）方面的有效性。随着新的临床研究的进展，支持 EPA 健康效用的证据将会增加，并可能开发出含有这种重要脂肪酸的新型药物配方。

此外，在动物营养领域，EPA 在宠物食品和养殖鱼类中的应用正在不断扩大。在宠物营养方面，EPA 现在被添加到狗粮和猫粮中，以支持关节健康、皮肤状况和整体健康。高端宠物食品日益流行，注重健康益处和高品质原料，这推动了对强化 EPA 等Omega-3脂肪酸的产品的需求。在水产养殖中，EPA 对于养殖鱼类的生长和健康至关重要，因为它可以提高饲料品质并改善鱼类的健康和生长率。全球对永续养殖鱼贝类的需求不断增加，进一步推动了 EPA 在水产养殖饲料中的使用。

技术进步如何影响 EPA 市场？

技术进步透过改进生产方法、萃取流程和产品配方对 EPA 市场产生了重大影响。一个显着的发展是提取技术的创新，它提高了天然 EPA 的产量和品质。超临界流体萃取和冷压等先进方法使製造商能够获得高纯度的 EPA 油，同时保留其有益特性。这些萃取技术不仅提高了 EPA 的生产效率，而且还减少了传统萃取方法对环境的影响。

此外，基于藻类的 EPA 的兴起正在彻底改变市场。随着消费者对永续性和道德采购的意识不断增强，以藻类为基础的 EPA 产品作为鱼类来源的可行替代品越来越受到支持。藻类油富含 EPA 和二十二碳六烯酸 (DHA)，是一种植物来源选择，对素食主义者、纯素食主义者和有环保意识的消费者俱有吸引力。高效藻类培养和提取技术的开发正在支持该行业的发展，扩大市场上富含 EPA 的产品的供应。

产品配方的进步也提高了 EPA 补充剂的有效性和生物利用度。乳化和封装技术的创新使得人们能够製造出更容易被人体吸收、具有稳定、高生物利用度的 EPA 产品。这样的配方可以提高 EPA 补充剂的整体有效性并提高消费者的满意度。此外，为了满足消费者对整体健康解决方案的偏好，结合其他有益成分（如 EPA 和 DHA、抗氧化剂和维生素）的补充剂配方变得越来越普遍。

此外，数位技术和资料分析有助于提高 EPA 市场消费者参与度和产品开发。公司越来越多地使用消费者反馈和市场研究资料来更好地了解消费者偏好并相应地定制他们的产品。这种资料主导的方法正在帮助製造商制定有针对性的行销策略和创新的 EPA 产品，以满足消费者不断变化的需求。

最后，对 EPA 健康益处的持续研究正在揭示新的潜在用途和治疗应用。随着对 EPA 在管理各种健康状况方面的作用的科学研究不断深入，其用途可能会不断扩大。人们对Omega-3脂肪酸重要性的认识不断提高，且越来越多的证据支持其对健康效用，预计将推动消费者和临床环境对富含 EPA 产品的需求。

推动 EPA 市场成长的因素有哪些？

EPA 市场的成长受到多种关键因素的推动，例如消费者对Omega-3脂肪酸健康益处的认识不断提高、对膳食补充剂的需求不断增加以及机能性食品领域的不断扩大。一个主要驱动因素是人们越来越意识到 EPA 在支持心血管健康、减少发炎和促进大脑功能方面的作用。随着消费者的健康意识增强并采取更积极的措施来改善健康，对 EPA 补充剂和强化产品的需求正在上升。

与生活方式相关的健康状况（包括肥胖、心臟病和精神疾病）的日益普遍，进一步推动了对 EPA 的需求。随着消费者寻求预防性保健措施， Omega-3补充剂，尤其是 EPA，越来越多地被视为支持整体健康的有益方法。这一趋势在老龄化社会尤其明显，人们正在寻求解决方案来维持认知功能并解决慢性健康问题。

机能性食品市场的扩大也是促进EPA市场成长的关键因素。消费者越来越寻求能够提供额外健康益处的食品，从而导致对 EPA 强化产品的需求增加。製造商透过在各种食品中添加 EPA 来满足这一需求，包括乳製品、零嘴零食以及食品和饮料产品。为消费者提供适合他们忙碌生活方式的健康和保健选择正在推动该行业的成长。

此外，永续植物来源饮食的趋势也引发了人们对藻类衍生的 EPA 产品的兴趣。随着越来越多的消费者采用素食和纯素生活方式，对替代来源的Omega-3脂肪酸的需求也日益增长。藻类油富含 EPA 和 DHA，对于希望在不依赖鱼类的情况下增加Omega-3摄入量的消费者来说，它提供了一种永续且合乎道德的选择。消费者偏好向植物来源产品的转变可能会继续对 EPA 市场产生正面影响。

最后，正在进行的针对 EPA 治疗应用的研究和临床研究正在推动市场成长。随着有关 EPA 在管理某些健康状况方面具有潜在效用的新证据不断涌现，医疗保健提供者越来越多地推荐Omega-3补充剂。越来越多的发现支持在临床环境中使用 EPA，并有助于 EPA 作为必需脂肪酸的广泛接受和利用。

总而言之，EPA 市场正在经历强劲增长，这得益于消费者对 EPA 健康益处的认识不断提高、对膳食补充剂和机能性食品的需求不断增加以及永续的植物来源营养趋势。生产和配方技术的进步，以及对 EPA 治疗益处的持续研究，预计将进一步增强 EPA 市场的未来前景。随着消费者越来越重视健康和保健，对富含 EPA 产品的需求预计将会增加，并影响营养和保健的未来。

部分

应用（营养保健品、机能性食品、宠物和动物饲料、婴儿奶粉、药物和其他应用）

受访公司范例（43家值得关注的公司）

  • BASF Nutrition
  • Croda
  • DSM
  • EPAX
  • GC Rieber Oils
  • KD Pharma
  • Orkla Health
  • Polaris
  • Shandong Yuwang Pharmaceutical
  • Sinomega

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲国家
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP17249

Global Eicosapentaenoic Acid Market to Reach US$6.5 Billion by 2030

The global market for Eicosapentaenoic Acid estimated at US$3.5 Billion in the year 2024, is expected to reach US$6.5 Billion by 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Dietary Supplements & Functional Foods Application, one of the segments analyzed in the report, is expected to record a 11.7% CAGR and reach US$4.9 Billion by the end of the analysis period. Growth in the Pet & Animal Feeds Application segment is estimated at 7.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$895.0 Million While China is Forecast to Grow at 14.4% CAGR

The Eicosapentaenoic Acid market in the U.S. is estimated at US$895.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 14.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.1% and 8.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.

Global Eicosapentaenoic Acid (EPA) Market – Key Trends & Drivers Summarized

What Is Eicosapentaenoic Acid (EPA), And Why Is It Important in Nutrition and Health?

Eicosapentaenoic acid (EPA) is an omega-3 fatty acid primarily found in fatty fish and certain algae. As a polyunsaturated fatty acid, EPA plays a critical role in human health, particularly in supporting cardiovascular function, reducing inflammation, and promoting brain health. EPA is commonly recognized for its anti-inflammatory properties, making it an important nutrient in the management of various health conditions, including cardiovascular diseases, arthritis, and mental health disorders. Additionally, EPA is known to contribute to the synthesis of bioactive compounds called eicosanoids, which help regulate various physiological processes in the body.

The importance of EPA in nutrition is highlighted by its numerous health benefits. Regular consumption of EPA has been linked to improved heart health by lowering triglyceride levels, reducing the risk of arrhythmias, and decreasing blood pressure. Moreover, EPA plays a significant role in mental health, with studies suggesting that adequate levels of this fatty acid may help alleviate symptoms of depression and anxiety. As consumers become more health-conscious, the demand for EPA-rich foods and supplements is on the rise, driving the growth of the EPA market.

What Are the Main Applications of EPA, And How Do They Cater to Nutritional Needs?

Eicosapentaenoic acid (EPA) has several key applications, primarily in dietary supplements, functional foods, pharmaceuticals, and animal nutrition. In the dietary supplement sector, EPA is commonly available in the form of fish oil capsules, krill oil, and algal oil supplements. These products cater to consumers seeking to enhance their omega-3 intake for various health benefits, such as supporting cardiovascular health and reducing inflammation. The popularity of EPA supplements has surged, particularly among health-conscious individuals and those with specific health concerns, leading to a growing market for these products.

In the functional foods segment, EPA is increasingly being incorporated into a variety of food products, including dairy items, beverages, and snack bars. Manufacturers are recognizing the potential market for health-enhancing products that provide added nutritional value. By fortifying everyday foods with EPA, brands can cater to consumers looking for convenient ways to incorporate beneficial omega-3 fatty acids into their diets. This trend is especially relevant as the demand for healthy, functional foods continues to grow among consumers seeking to improve their overall well-being.

EPA is also gaining attention in the pharmaceutical industry, where it is being explored for its therapeutic applications. Research is ongoing to evaluate the efficacy of EPA in managing various medical conditions, including cardiovascular disease, inflammatory disorders, and mental health issues. As new clinical studies emerge, they contribute to the growing body of evidence supporting the health benefits of EPA, potentially leading to new pharmaceutical formulations that incorporate this important fatty acid.

Additionally, the animal nutrition sector is increasingly utilizing EPA in pet foods and aquaculture. In pet nutrition, EPA is being included in dog and cat food formulations to support joint health, skin condition, and overall well-being. The growing trend of premium pet foods, which emphasize health benefits and high-quality ingredients, is driving demand for products fortified with omega-3 fatty acids like EPA. In aquaculture, EPA is crucial for the growth and health of farmed fish, as it enhances feed quality and improves fish health and growth rates. The rising global demand for sustainably farmed seafood is further promoting the use of EPA in aquaculture feeds.

How Are Technological Advancements Impacting the EPA Market?

Technological advancements are significantly influencing the EPA market by improving production methods, extraction processes, and product formulations. One notable development is the innovation in extraction technologies that enhance the yield and quality of EPA from natural sources. Advanced methods, such as supercritical fluid extraction and cold pressing, enable manufacturers to obtain high-purity EPA oils while preserving their beneficial properties. These extraction techniques not only improve the efficiency of EPA production but also reduce the environmental impact associated with traditional extraction methods.

Moreover, the rise of algae-based sources of EPA is transforming the market landscape. As consumers become more aware of sustainability and ethical sourcing, algae-derived EPA products are gaining traction as a viable alternative to fish-based sources. Algal oil, which is rich in both EPA and docosahexaenoic acid (DHA), provides a plant-based option that appeals to vegetarians, vegans, and environmentally conscious consumers. The development of efficient algal cultivation and extraction technologies is supporting the growth of this segment, expanding the availability of EPA-rich products in the market.

Advancements in product formulation are also enhancing the efficacy and bioavailability of EPA supplements. Innovations in emulsification and encapsulation technologies allow for the creation of more stable and bioavailable EPA products that are easier for the body to absorb. These formulations can improve the overall effectiveness of EPA supplements and enhance consumer satisfaction. Additionally, the combination of EPA with other beneficial ingredients, such as DHA, antioxidants, and vitamins, is becoming increasingly common in supplement formulations, catering to consumer preferences for comprehensive health solutions.

Furthermore, digital technology and data analytics are playing a role in improving consumer engagement and product development within the EPA market. Companies are utilizing consumer feedback and market research data to better understand consumer preferences and tailor their product offerings accordingly. This data-driven approach helps manufacturers create targeted marketing strategies and develop innovative EPA products that meet the evolving needs of consumers.

Finally, ongoing research into the health benefits of EPA is leading to new applications and potential therapeutic uses. As scientific studies continue to explore the role of EPA in managing various health conditions, the market is likely to see an expansion of its applications. Increased awareness of the importance of omega-3 fatty acids, along with growing evidence supporting their health benefits, will likely drive demand for EPA-rich products in both consumer and clinical settings.

What Is Driving the Growth in the EPA Market?

The growth in the EPA market is driven by several key factors, including increasing consumer awareness of the health benefits of omega-3 fatty acids, rising demand for dietary supplements, and the expansion of the functional foods sector. One of the primary drivers is the growing recognition of EPA's role in supporting cardiovascular health, reducing inflammation, and promoting brain function. As consumers become more health-conscious and proactive about their well-being, the demand for EPA supplements and fortified products is on the rise.

The increasing prevalence of lifestyle-related health conditions, such as obesity, heart disease, and mental health disorders, is further fueling the demand for EPA. Consumers are seeking preventive health measures, and omega-3 supplementation, particularly with EPA, is increasingly viewed as a beneficial approach to supporting overall health. This trend is particularly prominent among aging populations who are looking for solutions to maintain cognitive function and manage chronic health issues.

The expansion of the functional foods market is another significant factor contributing to the growth of the EPA market. Consumers are increasingly interested in foods that provide additional health benefits, leading to a rise in demand for EPA-fortified products. Manufacturers are responding to this demand by incorporating EPA into a variety of food items, including dairy products, snacks, and beverages. The ability to offer health-enhancing options that fit into consumers' busy lifestyles is driving the growth of this segment.

Additionally, the trend toward sustainable and plant-based diets is promoting interest in algae-derived EPA products. As more consumers adopt vegetarian and vegan lifestyles, the demand for alternative sources of omega-3 fatty acids is rising. Algal oil, rich in both EPA and DHA, presents a sustainable and ethical option for those seeking to increase their omega-3 intake without relying on fish sources. This shift in consumer preferences toward plant-based solutions is likely to continue influencing the EPA market positively.

Finally, ongoing research and clinical studies investigating the therapeutic applications of EPA are driving market growth. As new evidence emerges regarding the potential benefits of EPA in managing specific health conditions, healthcare providers are increasingly recommending omega-3 supplementation. This growing body of research supports the use of EPA in clinical settings, contributing to the broader acceptance and utilization of this essential fatty acid.

In conclusion, the EPA market is experiencing robust growth driven by increasing consumer awareness of its health benefits, rising demand for dietary supplements and functional foods, and the trend toward sustainable and plant-based nutrition. Technological advancements in production and formulation, coupled with ongoing research into the therapeutic potential of EPA, will further enhance the market's prospects. As consumers prioritize their health and well-being, the demand for EPA-rich products is expected to flourish, shaping the future of nutrition and wellness.

SCOPE OF STUDY:

The report analyzes the Eicosapentaenoic Acid market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • BASF Nutrition
  • Croda
  • DSM
  • EPAX
  • GC Rieber Oils
  • KD Pharma
  • Orkla Health
  • Polaris
  • Shandong Yuwang Pharmaceutical
  • Sinomega

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Eicosapentaenoic Acid - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Omega-3 Fatty Acids in Dietary Supplements Drives Growth of Eicosapentaenoic Acid (EPA) Market
    • Increased Adoption of EPA in Cardiovascular Health Products Expands Addressable Market
    • Surge in Demand for EPA in Functional Foods and Beverages Fuels Market Growth
    • Technological Advancements in EPA Extraction from Fish and Algae Propel Market Expansion
    • Growing Focus on EPA for Anti-Inflammatory and Joint Health Benefits Strengthens Business Case
    • Rising Use of EPA in Cognitive and Brain Health Supplements Sets the Stage for Market Growth
    • Surge in Adoption of EPA in Sports Nutrition and Fitness Products Expands Market Opportunities
    • Growing Demand for EPA in Infant and Maternal Nutrition Expands Addressable Market
    • Rising Focus on EPA for Eye Health and Vision Support Fuels Market Demand
    • Technological Advancements in Microencapsulation of EPA for Enhanced Stability Propel Market Growth
    • Surge in Demand for EPA in Elderly Care and Cognitive Decline Prevention Expands Market Growth
    • Rising Use of EPA in Animal Nutrition Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Eicosapentaenoic Acid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Eicosapentaenoic Acid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Dietary Supplements & Functional Foods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Dietary Supplements & Functional Foods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Dietary Supplements & Functional Foods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Infant Formula by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Infant Formula by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Infant Formula by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Eicosapentaenoic Acid Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Pet & Animal Feeds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Pet & Animal Feeds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Pet & Animal Feeds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: Canada 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Japan Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Japan 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 29: China Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: China Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: China 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Eicosapentaenoic Acid by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Europe 15-Year Perspective for Eicosapentaenoic Acid by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Europe 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 38: France Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: France Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: France 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 41: Germany Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Germany Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Germany 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Italy Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Italy 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 47: UK Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: UK Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: UK 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 50: Spain Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Spain Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Spain 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 53: Russia Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Russia Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Russia 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Rest of Europe Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Rest of Europe 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Eicosapentaenoic Acid by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Asia-Pacific 15-Year Perspective for Eicosapentaenoic Acid by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Asia-Pacific 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 65: Australia Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Australia Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Australia 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 68: India Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: India Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: India 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 71: South Korea Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: South Korea Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: South Korea 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 74: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Rest of Asia-Pacific Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Rest of Asia-Pacific 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Eicosapentaenoic Acid by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Latin America 15-Year Perspective for Eicosapentaenoic Acid by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 80: Latin America Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Latin America Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Latin America 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 83: Argentina Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Argentina Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Argentina 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 86: Brazil Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Brazil Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Brazil 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 89: Mexico Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Mexico Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Mexico 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 92: Rest of Latin America Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Latin America Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Latin America 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Eicosapentaenoic Acid by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Middle East 15-Year Perspective for Eicosapentaenoic Acid by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 98: Middle East Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Middle East Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Middle East 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 101: Iran Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Iran Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Iran 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 104: Israel Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Israel Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Israel 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 107: Saudi Arabia Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Saudi Arabia Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Saudi Arabia 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 110: UAE Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UAE Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UAE 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 113: Rest of Middle East Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Middle East Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Rest of Middle East 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 116: Africa Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Africa Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Africa 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION